Stacy Lindborg

Stacy Lindborg

Company: BrainStorm Cell Therapeutics

Job title: Chief Development Officer


Reviewing ALSFRS-R as the Established Endpoint for ALS Clinical Trials 2:30 pm

• Demonstrating and quantifying challenges with the ALSFRS-R endpoint in its current state • Showcasing evidence from alternative measurements to demonstrate impact on disease progression • Outlining ongoing strategy to approach regulatory review through leveraging regulatory flexibilityRead more

day: Day Two AM

Panel Discussion: A Year in Review: Showcasing the Breakthrough Developments in ALS Drug Development 9:00 am

• Reviewing the ground-breaking developments in ALS drug development in the past year • Understanding the impact on people living with ALS, clinicians, drug developers and regulatory bodies • Looking to the future: what are the steps towards the next generation of ALS therapeutics?Read more

day: Day One AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.